Bird flu vaccine that cost Spain EUR 120m may be useless
The EUR 120 million stockpiling of drugs to fight bird flu infections could soon be ineffective, says scientists.15 May 2008
MADRID - Spain has spent EUR 120 million stockpiling doses of a drug to fight bird flu infections in humans that scientists are now warning could soon be ineffective.
According to a report published on Wednesday in the journal Nature, mutations of the H5N1 bird flu virus are making it resistant to Tamiflu, the principal drug that Spain and most other countries started stockpiling in 2005 at the height of the bird flu pandemic.
Another drug, Relenza, which few countries bought, so far appears to still be effective.
Spain spent EUR 120 million on 12 million doses of Tamiflu in 2005.
[El Pais / Expatica]